Hepatitis B clinical trials at UCLA
1 in progress, 0 open to eligible people
Showing trials for
Duo: A Phase IIIb Individual-Level Randomized Controlled Trial of an Integrated Strategy
Sorry, not yet accepting patients
Individual-Level Randomized Controlled Trial of an Integrated Strategy of HIV pre-exposure prophylaxis (PrEP) and sexually transmitted infection (STI) post-exposure prophylaxis (PEP) for Young Men
Los Angeles, California and other locations
Our lead scientists for Hepatitis B research studies include Jesse Clark, MD.
Last updated: